GeneDx Holdings Corp.
WGS
$86.48
$0.610.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 71.98% | -258.41% | -131.38% | -170.64% | 265.55% |
| Total Depreciation and Amortization | -1.40% | 13.84% | -7.62% | 4.57% | 9.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.09% | 467.15% | -57.91% | 102.88% | 27.04% |
| Change in Net Operating Assets | 2.26% | -8,940.46% | 109.13% | 82.43% | -587.59% |
| Cash from Operations | 10.57% | -948.80% | -119.60% | 51.31% | 2.34% |
| Capital Expenditure | -56.73% | -48.45% | 29.57% | -160.53% | 61.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 141.51% | -52.92% | -575.69% | 288.93% | 76.03% |
| Cash from Investing | 67.37% | -55.84% | -136.23% | 87.11% | -286.37% |
| Total Debt Issued | -100.31% | -- | -- | -- | -200.00% |
| Total Debt Repaid | 99.17% | -8,542.52% | 43.91% | -42.56% | 6.37% |
| Issuance of Common Stock | 235.77% | -97.76% | 99.22% | -20.60% | 1,953.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.40% | 66.39% | 115.39% | 3,012.14% | -97.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -203.49% | -222.61% | -58.66% | 185.40% | -276.54% |